# Lawrence S. Phillips

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lawrence-s-phillips/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,078 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 86 |
| i10-index | 320 |
| Last Known Institution | Emory University |
| OpenAlex ID | https://openalex.org/A5061795428 |
| ORCID iD | https://orcid.org/0000-0002-6542-8046 |
| Works | 526 |

## Researcher papers

- [Calcium plus Vitamin D Supplementation and the Risk of Fractures](https://scholariq.org/papers/calcium-plus-vitamin-d-supplementation-and-the-risk-of-fractures/)
- [Low-Fat Dietary Pattern and Risk of Cardiovascular Disease](https://scholariq.org/papers/low-fat-dietary-pattern-and-risk-of-cardiovascular-disease/)
- [Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer](https://scholariq.org/papers/calcium-plus-vitamin-d-supplementation-and-the-risk-of-colorectal-cancer/)
- [Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant](https://scholariq.org/papers/treatment-of-acromegaly-with-the-growth-hormone-receptor-antagonist-pegvisomant/)
- [Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis](https://scholariq.org/papers/discovery-of-318-new-risk-loci-for-type-2-diabetes-and-related-vascular-outcomes/)
- [Vitamin D Supplementation and Prevention of Type 2 Diabetes](https://scholariq.org/papers/vitamin-d-supplementation-and-prevention-of-type-2-diabetes/)
- [Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist](https://scholariq.org/papers/long-term-treatment-of-acromegaly-with-pegvisomant-a-growth-hormone-receptor/)
- [Review of methods for detecting glycemic disorders](https://scholariq.org/papers/review-of-methods-for-detecting-glycemic-disorders/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)
- [Diabetes Management and Education](https://scholariq.org/topics/diabetes-management-and-education/)

## Researcher university

- [Emory University](https://scholariq.org/institutions/emory-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.